US Stock MarketDetailed Quotes

CME CME Group

Watchlist
  • 277.110
  • +0.030+0.01%
Close May 1 16:00 ET
  • 277.110
  • 0.0000.00%
Post 20:01 ET
99.86BMarket Cap27.88P/E (TTM)

CME Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.08%1.12B
6.85%3.69B
-2.53%1.02B
17.08%1B
19.45%776.9M
-1.07%892.7M
13.02%3.45B
6.40%1.04B
30.24%856.7M
5.31%650.4M
Net income from continuing operations
11.81%956.2M
9.29%3.53B
7.37%874.6M
21.67%912.8M
13.58%883.2M
-3.24%855.2M
19.89%3.23B
27.70%814.6M
10.39%750.2M
17.37%777.6M
Operating gains losses
-4.00%-2.6M
95.01%-3.6M
2,800.00%8.1M
--0
-936.36%-9.2M
96.66%-2.5M
-1,402.08%-72.1M
57.14%-300K
272.73%1.9M
120.00%1.1M
Depreciation and amortization
-3.28%82.5M
-4.48%336.8M
-3.36%83.4M
-4.98%83.9M
-5.71%84.2M
-3.83%85.3M
-2.76%352.6M
-4.75%86.3M
-1.89%88.3M
-0.89%89.3M
Deferred tax
0.00%-7.4M
11.47%-66.4M
9.55%-44.5M
13.95%-7.4M
16.47%-7.1M
14.94%-7.4M
-223.28%-75M
-4,372.73%-49.2M
14.85%-8.6M
-23.19%-8.5M
Other non cash items
58.33%5.7M
-108.72%-3M
-81.75%2.3M
-24.07%12.3M
-105.83%-21.2M
-77.36%3.6M
-16.71%34.4M
-70.21%12.6M
357.14%16.2M
29.93%-10.3M
Change In working capital
194.14%61M
-98.11%-188.6M
-57.12%66.9M
-85.29%-18.9M
21.30%-171.8M
-185.46%-64.8M
0.00%-95.2M
-16.58%156M
91.03%-10.2M
-63.77%-218.3M
-Change in receivables
-110.71%-196.8M
23.50%-39.4M
138.46%55.8M
-172.79%-29.7M
-77.77%27.9M
61.28%-93.4M
-0.78%-51.5M
-75.70%23.4M
6,700.00%40.8M
382.69%125.5M
-Change in payables and accrued expense
75.22%301.2M
-18.72%-128.1M
-185.47%-39.4M
124.40%8.2M
29.02%-268.8M
-33.45%171.9M
-43.29%-107.9M
-0.43%46.1M
66.86%-33.6M
-73.64%-378.7M
-Change in other current assets
-96.44%16.5M
235.62%740.2M
120.62%103.4M
71.93%-22.6M
616.09%195.6M
525.91%463.8M
-5,298.10%-545.8M
-1,266.49%-501.5M
-670.92%-80.5M
-145.23%-37.9M
-Change in other current liabilities
90.13%-59.9M
-224.80%-761.3M
-109.00%-52.9M
-60.06%25.2M
-273.76%-126.5M
-433.01%-607.1M
2,846.86%610M
625.03%588M
333.70%63.1M
391.20%72.8M
Cash from discontinued investing activities
Operating cash flow
25.08%1.12B
6.85%3.69B
-2.53%1.02B
17.08%1B
19.45%776.9M
-1.07%892.7M
13.02%3.45B
6.40%1.04B
30.24%856.7M
5.31%650.4M
Investing cash flow
Cash flow from continuing investing activities
29.82%-16M
-495.22%-82.6M
-24.02%-25.3M
-51.28%-29.5M
-106.41%-5M
-32.56%-22.8M
104.27%20.9M
20.62%-20.4M
17.37%-19.5M
118.68%78M
Net PPE purchase and sale
28.28%-14.2M
-23.04%-94M
-25.96%-26.2M
-49.75%-29.8M
11.22%-18.2M
-30.26%-19.8M
14.83%-76.4M
14.75%-20.8M
17.08%-19.9M
-14.53%-20.5M
Net business purchase and sale
31.43%-2.4M
-89.63%9.9M
-86.21%13.5M
--0
---100K
-45.83%-3.5M
123.76%95.5M
975.82%97.9M
--0
--0
Net investment purchase and sale
20.00%600K
-16.67%1.5M
87.08%-12.6M
-25.00%300K
-86.50%13.3M
25.00%500K
-5.26%1.8M
-837.50%-97.5M
0.00%400K
764.04%98.5M
Cash from discontinued investing activities
Investing cash flow
29.82%-16M
-495.22%-82.6M
-24.02%-25.3M
-51.28%-29.5M
-106.41%-5M
-32.56%-22.8M
104.27%20.9M
20.62%-20.4M
17.37%-19.5M
118.68%78M
Financing cash flow
Cash flow from continuing financing activities
892.12%19.21B
110.50%5.08B
-138.02%-984.1M
150.43%13.35B
39.57%-9.22B
121.05%1.94B
-90.45%-48.34B
150.84%2.59B
-2,380.44%-26.47B
48.56%-15.26B
Net issuance payments of debt
---7.7M
--0
--0
--0
--0
--0
-7.89%-16.4M
--0
--0
----
Cash dividends paid
-10.26%-2.57B
-10.78%-3.58B
-4.67%-418.8M
-4.63%-418.5M
-4.68%-418.5M
-14.38%-2.33B
-22.86%-3.24B
-10.07%-400.1M
-10.13%-400M
-10.05%-399.8M
Net other financing activities
410.84%21.79B
119.21%8.66B
-118.92%-565.3M
152.81%13.77B
40.70%-8.8B
159.54%4.26B
-98.33%-45.09B
163.21%2.99B
-1,810.64%-26.07B
49.34%-14.85B
Cash from discontinued financing activities
Financing cash flow
892.12%19.21B
110.50%5.08B
-138.02%-984.1M
150.43%13.35B
39.57%-9.22B
121.05%1.94B
-90.45%-48.34B
150.84%2.59B
-2,380.44%-26.47B
48.56%-15.26B
Net cash flow
Beginning cash position
9.33%101.79B
-32.52%93.11B
13.73%101.79B
-24.03%87.47B
-26.03%95.92B
-32.52%93.11B
-14.19%137.97B
-37.02%89.5B
-17.95%115.13B
-23.63%129.66B
Current changes in cash
623.80%20.31B
119.36%8.68B
-99.76%8.5M
155.87%14.32B
41.85%-8.45B
133.76%2.81B
-96.64%-44.86B
187.35%3.61B
-1,527.99%-25.63B
50.69%-14.53B
End cash Position
27.31%122.11B
9.33%101.79B
9.33%101.79B
13.73%101.79B
-24.03%87.47B
-26.03%95.92B
-32.52%93.11B
-32.52%93.11B
-37.02%89.5B
-17.95%115.13B
Free cash flow
26.29%1.1B
6.49%3.6B
-3.11%991.7M
16.30%973.2M
20.45%758.7M
-1.61%872.9M
13.86%3.38B
6.94%1.02B
32.03%836.8M
5.04%629.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.08%1.12B6.85%3.69B-2.53%1.02B17.08%1B19.45%776.9M-1.07%892.7M13.02%3.45B6.40%1.04B30.24%856.7M5.31%650.4M
Net income from continuing operations 11.81%956.2M9.29%3.53B7.37%874.6M21.67%912.8M13.58%883.2M-3.24%855.2M19.89%3.23B27.70%814.6M10.39%750.2M17.37%777.6M
Operating gains losses -4.00%-2.6M95.01%-3.6M2,800.00%8.1M--0-936.36%-9.2M96.66%-2.5M-1,402.08%-72.1M57.14%-300K272.73%1.9M120.00%1.1M
Depreciation and amortization -3.28%82.5M-4.48%336.8M-3.36%83.4M-4.98%83.9M-5.71%84.2M-3.83%85.3M-2.76%352.6M-4.75%86.3M-1.89%88.3M-0.89%89.3M
Deferred tax 0.00%-7.4M11.47%-66.4M9.55%-44.5M13.95%-7.4M16.47%-7.1M14.94%-7.4M-223.28%-75M-4,372.73%-49.2M14.85%-8.6M-23.19%-8.5M
Other non cash items 58.33%5.7M-108.72%-3M-81.75%2.3M-24.07%12.3M-105.83%-21.2M-77.36%3.6M-16.71%34.4M-70.21%12.6M357.14%16.2M29.93%-10.3M
Change In working capital 194.14%61M-98.11%-188.6M-57.12%66.9M-85.29%-18.9M21.30%-171.8M-185.46%-64.8M0.00%-95.2M-16.58%156M91.03%-10.2M-63.77%-218.3M
-Change in receivables -110.71%-196.8M23.50%-39.4M138.46%55.8M-172.79%-29.7M-77.77%27.9M61.28%-93.4M-0.78%-51.5M-75.70%23.4M6,700.00%40.8M382.69%125.5M
-Change in payables and accrued expense 75.22%301.2M-18.72%-128.1M-185.47%-39.4M124.40%8.2M29.02%-268.8M-33.45%171.9M-43.29%-107.9M-0.43%46.1M66.86%-33.6M-73.64%-378.7M
-Change in other current assets -96.44%16.5M235.62%740.2M120.62%103.4M71.93%-22.6M616.09%195.6M525.91%463.8M-5,298.10%-545.8M-1,266.49%-501.5M-670.92%-80.5M-145.23%-37.9M
-Change in other current liabilities 90.13%-59.9M-224.80%-761.3M-109.00%-52.9M-60.06%25.2M-273.76%-126.5M-433.01%-607.1M2,846.86%610M625.03%588M333.70%63.1M391.20%72.8M
Cash from discontinued investing activities
Operating cash flow 25.08%1.12B6.85%3.69B-2.53%1.02B17.08%1B19.45%776.9M-1.07%892.7M13.02%3.45B6.40%1.04B30.24%856.7M5.31%650.4M
Investing cash flow
Cash flow from continuing investing activities 29.82%-16M-495.22%-82.6M-24.02%-25.3M-51.28%-29.5M-106.41%-5M-32.56%-22.8M104.27%20.9M20.62%-20.4M17.37%-19.5M118.68%78M
Net PPE purchase and sale 28.28%-14.2M-23.04%-94M-25.96%-26.2M-49.75%-29.8M11.22%-18.2M-30.26%-19.8M14.83%-76.4M14.75%-20.8M17.08%-19.9M-14.53%-20.5M
Net business purchase and sale 31.43%-2.4M-89.63%9.9M-86.21%13.5M--0---100K-45.83%-3.5M123.76%95.5M975.82%97.9M--0--0
Net investment purchase and sale 20.00%600K-16.67%1.5M87.08%-12.6M-25.00%300K-86.50%13.3M25.00%500K-5.26%1.8M-837.50%-97.5M0.00%400K764.04%98.5M
Cash from discontinued investing activities
Investing cash flow 29.82%-16M-495.22%-82.6M-24.02%-25.3M-51.28%-29.5M-106.41%-5M-32.56%-22.8M104.27%20.9M20.62%-20.4M17.37%-19.5M118.68%78M
Financing cash flow
Cash flow from continuing financing activities 892.12%19.21B110.50%5.08B-138.02%-984.1M150.43%13.35B39.57%-9.22B121.05%1.94B-90.45%-48.34B150.84%2.59B-2,380.44%-26.47B48.56%-15.26B
Net issuance payments of debt ---7.7M--0--0--0--0--0-7.89%-16.4M--0--0----
Cash dividends paid -10.26%-2.57B-10.78%-3.58B-4.67%-418.8M-4.63%-418.5M-4.68%-418.5M-14.38%-2.33B-22.86%-3.24B-10.07%-400.1M-10.13%-400M-10.05%-399.8M
Net other financing activities 410.84%21.79B119.21%8.66B-118.92%-565.3M152.81%13.77B40.70%-8.8B159.54%4.26B-98.33%-45.09B163.21%2.99B-1,810.64%-26.07B49.34%-14.85B
Cash from discontinued financing activities
Financing cash flow 892.12%19.21B110.50%5.08B-138.02%-984.1M150.43%13.35B39.57%-9.22B121.05%1.94B-90.45%-48.34B150.84%2.59B-2,380.44%-26.47B48.56%-15.26B
Net cash flow
Beginning cash position 9.33%101.79B-32.52%93.11B13.73%101.79B-24.03%87.47B-26.03%95.92B-32.52%93.11B-14.19%137.97B-37.02%89.5B-17.95%115.13B-23.63%129.66B
Current changes in cash 623.80%20.31B119.36%8.68B-99.76%8.5M155.87%14.32B41.85%-8.45B133.76%2.81B-96.64%-44.86B187.35%3.61B-1,527.99%-25.63B50.69%-14.53B
End cash Position 27.31%122.11B9.33%101.79B9.33%101.79B13.73%101.79B-24.03%87.47B-26.03%95.92B-32.52%93.11B-32.52%93.11B-37.02%89.5B-17.95%115.13B
Free cash flow 26.29%1.1B6.49%3.6B-3.11%991.7M16.30%973.2M20.45%758.7M-1.61%872.9M13.86%3.38B6.94%1.02B32.03%836.8M5.04%629.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Earnings Season Underway

Earnings season is here. What to know?